Marine-Based Nutraceuticals: An Innovative Trend in the Food and Supplement Industries
AbstractRecent trends in functional foods and supplements have demonstrated that bioactive molecules play a major therapeutic role in human disease. Nutritionists and biomedical and food scientists are working together to discover new bioactive molecules that have increased potency and therapeutic benefits. Marine life constitutes almost 80% of the world biota with thousands of bioactive compounds and secondary metabolites derived from marine invertebrates such as tunicates, sponges, molluscs, bryozoans, sea slugs and many other marine organisms. These bioactive molecules and secondary metabolites possess antibiotic, antiparasitic, antiviral, anti-inflammatory, antifibrotic and anticancer activities. They are also inhibitors or activators of critical enzymes and transcription factors, competitors of transporters and sequestrants that modulate various physiological pathways. The current review summaries the widely available marine-based nutraceuticals and recent research carried out for the purposes of isolation, identification and characterization of marine-derived bioactive compounds with various therapeutic potentials. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Suleria, H.A.R.; Osborne, S.; Masci, P.; Gobe, G. Marine-Based Nutraceuticals: An Innovative Trend in the Food and Supplement Industries. Mar. Drugs 2015, 13, 6336-6351.
Suleria HAR, Osborne S, Masci P, Gobe G. Marine-Based Nutraceuticals: An Innovative Trend in the Food and Supplement Industries. Marine Drugs. 2015; 13(10):6336-6351.Chicago/Turabian Style
Suleria, Hafiz A.R.; Osborne, Simone; Masci, Paul; Gobe, Glenda. 2015. "Marine-Based Nutraceuticals: An Innovative Trend in the Food and Supplement Industries." Mar. Drugs 13, no. 10: 6336-6351.